NeuroPace (NPCE) Short-term Investments (2020 - 2026)

NeuroPace's Short-term Investments history runs 7 years deep, the most recent figure standing at $39.2 million for Q1 2026.

• On a quarterly basis, Short-term Investments changed 0.1% year-over-year to $39.2 million in Q1 2026; TTM through Mar 2026 was $39.2 million, a 0.1% change from a year earlier, with the FY2025 full-year figure at $39.4 million, changed 0.1% from the prior year.
• Short-term Investments steadied at $39.2 million in Q1 2026 per NPCE's latest filing, from $39.4 million in the prior quarter.
• Across five years, Short-term Investments topped out at $95.7 million in Q1 2022 and bottomed at $39.2 million in Q1 2026.
• The 5-year median for Short-term Investments is $45.9 million (2024), against an average of $53.8 million.
• Across the five-year window, Short-term Investments soared 473.35% in 2022 and tumbled 36.36% in 2023, its largest moves.
• Year by year, Short-term Investments stood at $70.8 million in 2022, then slumped by 31.65% to $48.4 million in 2023, then slipped by 18.74% to $39.3 million in 2024, then climbed by 0.1% to $39.4 million in 2025, then declined by 0.42% to $39.2 million in 2026.
• Per Business Quant, the three latest NPCE Short-term Investments figures stand at $39.2 million (Q1 2026), $39.4 million (Q4 2025), and $39.4 million (Q3 2025).